Parallax Volatility Advisers’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Parallax Volatility Advisers's NVO Position: Q1 2026 in Review
Parallax Volatility Advisers reduced its Novo Nordisk (NVO) stake by 74% in Q1 2026, selling an estimated $1.59M and leaving 11,936 shares worth $471K. The position accounts for ﹤0.01% of the portfolio, ranked #1071.
Parallax Volatility Advisers first reported a position in NVO in Q1 2018 and has held it in 17 quarters since. The position peaked at $12.1M in Q3 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Parallax Volatility Advisers held 11,936 shares of Novo Nordisk worth $471K as of Q1 2026.
- Parallax Volatility Advisers sold 33,490 Novo Nordisk shares in Q1 2026, an estimated $1.59M.
- Novo Nordisk made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #1071 holding.
- Parallax Volatility Advisers first reported a position in Novo Nordisk in Q1 2018 and has held it in 17 quarters since.
- Parallax Volatility Advisers's Novo Nordisk position peaked at $12.1M in Q3 2024.
- 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.